肺炎E病毒快速检测套组市场报告：趋势、预测和竞争分析（至2031年）

由于诊断中心、医院和家庭使用市场的需求，全球肺炎E病毒快速检测套组市场预计将成为一个前景看好的市场。该市场预计在2025年至2031年间将以4.6%的复合年增长率成长。主要成长要素包括戊型肝炎的日益普及、对快速诊断方法的需求不断增长以及人们对感染疾病的认识不断提高。

• 根据 Lucintel 的预测，胶体金在预测期内有望实现最高的成长率。
• 根据应用情况来看，诊断中心预计将迎来最高的成长率。
• 从区域来看，预计亚太地区在预测期内将达到最高的成长率。

快速肺炎E病毒检测套组市场的新趋势

肺炎E病毒快速检测套组市场正经历持续创新期，一系列关键趋势正在涌现，并改变产品开发和临床应用。这些变化直接源于医疗保健相关人员不断变化的需求，即更加重视早期检测、快速诊疗以及在资源匮乏环境下的可近性。这些趋势预示着市场正朝着更先进、更全面的解决方案发展，以促进HEV感染的快速且准确诊断。

• 即时检测技术的发展：一个关键趋势是开发可在医疗点使用的快速检测套组。这些检测操作简便，所需训练和基础设施极少。这显着提高了诊断的可及性，尤其是在检查室基础设施匮乏的偏远和资源匮乏地区。即时检测能够实现早期及时诊断，这对于控制疫情和即时医疗干预至关重要。
• 多重检测简介：目前正在研发的多重检测技术能够同时检测戊型肝炎病毒（HEV）和其他病毒性肝炎标记（例如甲型、B型和C型肝炎）。这使得单次检测即可进行鑑别诊断，从而提供了一种更有效率、更便捷的诊断方法，并能节省时间和成本。这对于临床上出现特异性急性肝炎症状的患者尤其重要。
• 提高灵敏度和特异性：快速检测套组灵敏度和特异性的持续提高是目前最重要的趋势之一。各公司正应用新型重组抗原和最新的免疫检测技术，以降低假阳性和假阴性的发生率。这提高了诊断准确性，增强了医护人员的信心，并有助于做出更准确的诊断。这一趋势在临床实践和公共卫生领域都发挥着至关重要的作用。
• 数位健康解决方案的整合：一项关键发展是将数位健康解决方案与快速检测套组整合，例如，利用行动应用程式解读检测结果，并将数据安全地传输到中央资料库，从而即时追踪流行病学模式。这将彻底改变公共卫生监测方式，使公共卫生部门更有效地追踪疫情爆发并部署资源。这一趋势利用科技来改善特定患者照护和整体公共卫生状况。
• 快速戊型肝炎病毒（HEV）快速检测套组的应用范围正稳定地扩展至兽医学和血液筛检领域，超越了人类临床诊断的范畴。这些应用包括兽医学领域，特别是猪的兽医学检测，以及捐血的常规筛检。这显着拓展了市场，使其涵盖了更多新领域。推动这一现象的因素是人们日益认识到HEV是一种通用感染疾病，以及确保血液製品安全性的迫切需求。

这些新兴趋势正在共同重塑肺炎E病毒快速检测套组市场。科技的进步，包括可及性和准确性的提高，满足了医护人员和病患的基本需求。向新应用和照护现场解决方案的多元化发展，正引领市场迈入新时代，巩固其作为全球公共卫生新格局中关键工具的地位。

肺炎E病毒快速检测套组市场近期趋势

过去几年，肺炎E病毒快速检测套组市场经历了许多重大发展，从根本上重新定义了其在现代医疗保健中的应用范围和价值。这些进步并非只是渐进式的改进，而是代表着一种旨在提升检测性能、增强临床疗效并解决紧迫的公共卫生和安全问题的策略性方法。这些进步主要得益于技术的进步以及对能够改善患者预后和优化医疗实践的产品的需求。

• 全自动免疫检测的出现：一项关键进展是用于检测戊型肝炎病毒（HEV）抗体和抗原的全自动免疫检测的出现。这项由大型诊断公司主导的创新标誌着检测方式从人工快速检测向自动化检测的重大转变，显着提高了检测效率并减少了人为误差。这些平台能够实现高通量筛检，这对于大型诊断检查室和血库，尤其是在已开发国家，至关重要。
• 戊型肝炎病毒（HEV）抗原检测试剂盒的研发：近期一项重要进展是HEV抗原快速检测套组的商业化。这意义重大，因为与单独检测抗体相比，抗原检测有助于更早诊断急性感染。这使得诊断更加及时准确，从而使临床医生能够更早启动治疗和患者管理。这项进展满足了疾病急性期快速诊断的重要临床需求。
• 关注戊型肝炎病毒（HEV）基因型鑑别：人们越来越关注开发能够区分主要HEV基因型（尤其是1型和3型基因型）的快速检测套组，这两种基因型在世界各地广泛流行。这不仅能提供更详细的HEV流行病学讯息，还能实现更有针对性的临床管理。这项创新对于监测工作至关重要，并可指南有针对性的公共卫生干预措施，以遏制特定HEV变异株的传播。
• 重组抗原的应用：製造商越来越多地采用重组抗原来提高快速检测套组的性能。基因工程抗原比源自天然病毒的抗原具有更高的纯度和均一性。这提高了试剂盒的敏感度和特异性，从而获得更可靠的结果，并减少了确认性检测的频率。这项优势有助于提高快速诊断平台的可靠性。
• 扩展的血清学和分子诊断组合：一项重要的进展是扩展了诊断组合，使其涵盖血清学（抗体）和分子（RNA）检测。这提供了一种全面的诊断方法，使临床医生能够区分急性感染和慢性感染并评估病毒量。这提高了诊断准确性，对于治疗复杂感染疾病（例如戊型肝炎病毒感染）至关重要，尤其是在免疫力缺乏的患者中。

这五项重大进展均对肺炎E病毒快速检测套组市场产生了显着影响。对高性能自动化、先进抗原检测和更高特异性的关注，使检测更加高效和通用。这些进展不仅改善了产品特性，还有助于提高患者照护水平和公共卫生监测能力，从而实现更有效地诊断和治疗戊型肝炎病毒感染。

目录

第一章执行摘要

第二章 市场概览

• 背景和分类
• 供应链

第三章：市场趋势与预测分析

• 产业驱动因素与挑战
• PESTLE分析
• 专利分析
• 法规环境

第四章 全球肺炎E病毒快速检测套组市场（按类型划分）

• 吸引力分析：按类型
• 酵素免疫分析法
• 探针法
• 胶体金法
• 其他的

5. 全球肺炎E病毒快速检测套组市场（依应用划分）

• 吸引力分析：依目的
• 诊断中心
• 医院
• 家用

第六章 区域分析

7. 北美肺炎E病毒快速检测套组市场

• 北美肺炎E病毒快速检测套组市场（按类型划分）
• 北美肺炎E病毒快速检测套组市场（按应用划分）
• 美国E型肺炎病毒快速检测套组的需求
• 墨西哥肺炎E病毒快速检测套组市场
• 加拿大肺炎E病毒快速检测套组市场

8. 欧洲肺炎E病毒快速检测套组市场

• 欧洲肺炎E病毒快速检测套组市场按类型划分
• 欧洲肺炎E病毒快速检测套组市场按应用领域划分
• 德国市场对肺炎E病毒快速检测套组
• 法国肺炎E病毒快速检测套组市场
• 西班牙肺炎E病毒快速检测套组市场
• 义大利肺炎E病毒快速检测套组市场
• 英国肺炎E病毒快速检测套组市场

9. 亚太地区肺炎E病毒快速检测套组市场

• 亚太地区肺炎E病毒快速检测套组市场（按类型划分）
• 亚太地区肺炎E病毒快速检测套组市场（依应用划分）
• 日本对E型肺炎病毒快速检测套组的需求
• 印度肺炎E病毒快速检测套组市场
• 中国E型肺炎病毒快速检测套组市场
• 韩国E型肺炎病毒快速检测套组市场
• 印尼肺炎E病毒快速检测套组市场

第十章 世界其他地区（ROW）肺炎E病毒快速检测套组市场

• ROW肺炎E病毒快速检测套组市场按类型划分
• ROW肺炎E病毒快速检测套组市场按应用领域划分
• 中东肺炎E病毒快速检测套组市场
• 南美洲肺炎E病毒快速检测套组市场
• 非洲肺炎E病毒快速检测套组市场

第十一章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析
• 市占率分析

第十二章：机会与策略分析

• 价值链分析
• 成长机会分析
• 全球肺炎E病毒快速检测套组市场新兴趋势
• 战略分析

第十三章：价值链中主要企业的概况

• 竞争分析
• CTK Biotech
• Abbexa
• Fortress Diagnostics
• MP Diagnostics
• Healgen
• Bio-Medical Laboratory Supplies
• Creative Diagnostics
• Athenese-Dx
• Biozek Medical
• Diagnostic Automation/Cortez Diagnostics

第十四章附录

The future of the global hepatitis E virus rapid test kit market looks promising with opportunities in the diagnostic center, hospital, and family expenses markets. The global hepatitis E virus rapid test kit market is expected to grow with a CAGR of 4.6% from 2025 to 2031. The major drivers for this market are the increasing prevalence of hepatitis E, the rising demand for rapid diagnostics, and the growing awareness of infectious diseases.

• Lucintel forecasts that, within the type category, colloidal gold method is expected to witness the highest growth over the forecast period.
• Within the application category, diagnostic center is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market is itself in a phase of ongoing innovation, with a number of leading trends emerging that are transforming its product development and clinical use. These changes are the direct result of the changing requirements of the healthcare fraternity, with an increased emphasis on the early detection, procedural expediency, and accessibility in resource-constrained environments. The trends indicate a shift towards more advanced and holistic solutions to facilitate fast and precise diagnosis of HEV infections.

• Point-of-Care Test Development: One major trend has been towards developing quick test kits for use at the point of care. Such tests are easy to use and need minimal training and infrastructure. The effect is a very high increase in accessibility to diagnosis, especially in remote or resource-poor areas where laboratory infrastructure is not available. POC tests allow for early and on-time diagnosis, which is essential in controlling outbreaks and allowing immediate medical intervention.
• Introduction of Multiplex Assays: Development of multiplex assays capable of detecting HEV in combination with other viral hepatitis markers, for example, Hepatitis A, B, or C, is on the increase. The effect is a superior and more efficient diagnostic test that reduces time and cost by allowing for differential diagnosis in one test. This is especially important in the clinical environment where patients may have non-specific acute hepatitis symptoms.
• Increased Sensitivity and Specificity: One of the most important trends is the ongoing improvement in the sensitivity and specificity of quick test kits. Companies are applying new recombinant antigens and newer immunoassay technologies to reduce the possibility of false positive and false negative results. The effect is an increased level of diagnostic accuracy, which enhances the confidence of healthcare professionals and delivers a more precise diagnosis. This trend plays a vital role in both clinical and public health applications.
• Integration of Digital Health Solutions: One major development is the integration of digital health solutions with rapid test kits. Examples include mobile apps that can interpret test results and securely send data to a central database for real-time tracking of epidemiological patterns. The effect is a new revolution in public health surveillance, allowing public health authorities to track outbreaks and deploy resources better. This trend utilizes technology to enhance both specific patient care and general public health outcomes.
• Expansion into Veterinary Medicine and Blood Screening: There is a definitive and increasing tendency to use HEV rapid test kits in new uses outside of human clinical diagnostics. These include a concentration on veterinary medicine, especially for swine, and routine screening of blood donations. The effect is the extensive growth of the market into new areas. This phenomenon is fueled by increasing awareness of HEV as a zoonotic infection and a requirement for ensuring the safety of blood products.

Combined, these new trends are redefining the hepatitis E virus rapid test kit market. The move toward greater accessibility, encompassing technology, and increased accuracy is meeting the fundamental requirements of both practitioners and patients. The diversification into new uses and point-of-care solutions are bringing the market into the new era and cementing its position as a key tool in the new world of global public health.

Recent Developments in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market has witnessed a number of important developments over the past few years that are essentially redefining its application and worth in contemporary medicine. These are not mere incremental refinements but are indicative of a strategic approach towards improving test performance, increasing clinical efficacy, and responding to compelling public health and safety issues. These advances are fueled mainly by advances in technology and the need for products that enhance patient outcomes and optimize medical practice.

• Release of Fully Automated Immunoassays: A principal development is the release of fully automated immunoassay analyzers to detect HEV antibody and antigen. This innovation, spearheaded by the leading diagnostic firms, represents a principal move away from manual quick tests. The effect is a tremendous enhancement of testing efficiency and less human error. These platforms allow high-throughput screening, which is a critical requirement for large diagnostic labs and blood banks, especially in the developed world.
• HEV Antigen Detection Kit Development: A significant recent improvement has been the commercial release of rapid test kits for detecting the HEV antigen. This is significant because antigen detection can lead to earlier diagnosis of acute infection compared to antibody detection in isolation. The consequence is an earlier and more accurate diagnosis, enabling clinicians to initiate treatment or patient management earlier. This development addresses a key clinical need for rapid diagnosis in the acute phase of the disease.
• Emphasis on HEV Genotype Differentiation: Of increasing interest is the creation of rapid test kits that can distinguish between the main HEV genotypes, especially genotypes 1 and 3, which are common in various parts of the world. The effect is finer-grained information regarding HEV epidemiology as well as more targeted clinical management. This innovation is important for research and surveillance and can guide targeted public health interventions to contain the transmission of particular HEV variants.
• Recombinant Antigen Use: There is a growing trend among manufacturers to employ recombinant antigens in their rapid test kits to enhance performance. The genetically engineered antigens provide greater purity and consistency than their native virus counterparts. The result is enhanced sensitivity and specificity of the kits, resulting in more dependable results as well as less confirmatory testing. This advantage contributes to increased confidence in the rapid diagnostic platform.
• Enlargement of Serological and Molecular Diagnostic Panels: An important advance is the enlargement of diagnostic panels to cover both serological (antibody) and molecular (RNA) HEV tests. This gives a complete approach to diagnosis, enabling clinicians to identify both acute and chronic infection and assess viral load. The effect is an enhanced diagnostic picture that is vital in dealing with a complicated infection like HEV, especially in immunocompromised hosts.

All of these five major advancements are profoundly influencing the hepatitis E virus rapid test kit market. Emphasis on high-performance automation, advanced antigen detection, and enhanced specificity is rendering the tests more efficient and versatile. These advancements are not only enhancing product characteristics but also assisting in enhancing the level of patient care and public health surveillance so that HEV can be diagnosed and treated more effectively.

Strategic Growth Opportunities in the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market offers many strategic growth opportunities across major applications, fueled by the intersection of technological innovation, demographic change, and changing public health needs. Although the market appears niche in nature, innovation and specialization are bringing new areas of expansion. These opportunities emphasize the use of the inherent strengths of rapid tests, for instance, speed and simplicity, to improve their performance and utility in a broader array of clinical and public health environments.

• Public Health Surveillance and Outbreak Control: This market is a core and established growth opportunity. The large frequency of HEV outbreaks in developing countries and the urgency to react quickly with a public health response establish a permanent and high-volume market. Firms can specialize in producing and commercializing rapid test kits for public health applications, which can capture a large and stable market share and form close collaborations with government and non-governmental agencies engaged in disease control activities.
• Screening of Blood and Organ Donors: Screening blood and organ donors for HEV is a significant growth opportunity. There is increasing consciousness of the risk of HEV transmission via blood transfusion and organ transplantation, and this has resulted in more stringent screening regulations. By developing and selling very sensitive HEV rapid tests to blood banks and transplant facilities, businesses are able to sell into a high-value niche segment of the market and help make a dramatic increase in patient safety.
• Veterinary Medicine: The veterinary industry is an important growth prospect. HEV is a recognized zoonotic infection, and swine is an important reservoir. There is growing demand for HEV surveillance in animals, especially in pig farms, to avoid both animal and human infections. Businesses can ride on this trend by creating HEV rapid test kits for veterinary applications. This market focus can ensure deeper market penetration and create a new, expanding application field.
• Immunocompromised Patient Diagnostics: Immunocompromised patient diagnostics, including those with HIV or transplant recipients, represent a prime area for HEV diagnostic growth. In these patients, HEV has the potential to cause chronic infection and liver disease, and thus early detection is essential. Firms may target the development of highly sensitive rapid test kits specifically validated for use in these patients to meet a high-value and critical clinical need.
• Travel Health and Screening: With the resumption of international travel, there is also an increased emphasis on screening passengers for infectious diseases, especially returnees from endemic areas. This is a stable and sustainable growth potential. By packaging HEV rapid test kits as part of a travel health clinic or a screening program, businesses can address an important need and diversify their product line into a new and critical segment of the market.

These opportunities for strategic growth are influencing the hepatitis E virus rapid test kit market by moving away from a one-size-fits-all solution to focused, application-specific solutions. Through product specialization in high-growth applications such as blood screening and veterinary medicine, and through leveraging the fast growth of public health surveillance programs, firms can maintain the profitability and relevance of HEV rapid tests despite a competitive and changing medical environment.

Hepatitis E Virus Rapid Test Kit Market Driver and Challenges

The hepatitis E virus rapid test kit market is influenced by a dynamic relationship of key drivers that fuel its expansion and key challenges that can limit its growth. The drivers, namely the high incidence of HEV and increasing emphasis on public health, are driving the market, whereas challenges of no standard diagnostic method and existing low-cost substitutes need to be addressed through careful strategy management. Comprehending this equilibrium is important for firms in this market to develop winning strategies for success.

The factors responsible for driving the hepatitis E virus rapid test kit market include:

1. High Incidence of Hepatitis E: One of the main drivers is the high worldwide incidence of HEV, especially among developing nations in Asia and Africa. HEV is a major cause of acute viral hepatitis, and its route of transmission via polluted water and food sources provides a constant and large patient base for diagnosis. This large disease burden is an underlying force that guarantees a consistent demand for quick test kits, and as such, it is a stable market with high growth prospects.

2. Growing Awareness and Public Health Programs: The increasing awareness of HEV among the general public and healthcare providers is a key market force. Public health programs and government policies aimed at containing viral hepatitis outbreaks are driving demand for screening and surveillance products. This emphasis on public health is driving the demand for rapid test kits to become widespread across endemic areas in order to enable early diagnosis and outbreak control.

3. Movement Towards Point-of-Care Diagnosis: The worldwide movement towards point-of-care (POC) testing is the principal driving force behind the HEV rapid test kit market. POC tests provide quick diagnosis without the requirement of advanced laboratory facilities, which is an imperative for the control of HEV in rural or resource-constrained environments. This transition is increasing HEV diagnosis accessibility and efficiency, which, in turn, drives the market growth through increased potential demand from more users.

4. Increasing Prevalence of Zoonotic Transmission: With growing awareness of HEV as a zoonotic infection, especially in the developed world where eating contaminated pork and other animal products is the leading cause of infection, there has emerged a new market demand for HEV diagnostics. The necessity to test human patients as well as animal populations is a prime driver that is furthering the market into new applications such as veterinary diagnostics and food safety.

5. Significance of Blood and Organ Screening: The heightened concern regarding the risk of HEV transmission by blood transfusions and organ transplant is a major impeller. This has initiated the drive for routine HEV screening of blood banks and transplant facilities. Bodies governing policy in certain geographies have advocated or mandated this screening, which represents a predictable and large-volume demand for highly sensitive rapid test kits, thus driving the market.

Challenges in the hepatitis E virus rapid test kit market are:

1. Absence of Standardized Diagnostic Method: One of the big challenges is the absence of a globally standardized diagnostic method for HEV. Different countries and clinical guidelines might suggest various testing methods, like serological tests versus molecular tests. This may result in confusion and variability in diagnosis and prove to be an impediment to market expansion. The absence of a standard makes it challenging for organizations to create one product that will serve all clinical purposes.

2. Substandard and Low-Cost Products: The market, especially in the developing world, is put under pressure by several low-cost, and at times substandard, rapid test kits. Such products can lack the necessary sensitivity or specificity, and therefore provide misleading results, and a lack of confidence among clinicians. This competition from untested products puts pressure on pricing and can also stifle the growth of firms that spend resources on research and development of high-quality products.

3. Lack of Awareness Outside Non-Endemic Areas: Although HEV is a problem in developed nations, public knowledge of the virus is generally poor. In most non-endemic areas, HEV is not included within normal screening panels, resulting in under-diagnosis and a restricted market. Poor awareness and a perceived low risk can be an important impediment to market growth and can hinder manufacturers from entering new markets.

The hepatitis E virus rapid test kit market is driven by strong drivers, namely a high disease burden and increasing emphasis on public health. Yet, the market is subjected to major challenges, mainly because of the absence of a standardized diagnostic strategy and the availability of low-quality, low-priced products. Its future will rely on whether it can utilize its benefits of saving lives by establishing a standard of quality and performance, thus surmounting the disadvantages of a splinter market and lack of universal knowledge.

List of Hepatitis E Virus Rapid Test Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis E virus rapid test kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis E virus rapid test kit companies profiled in this report include-

• CTK Biotech
• Abbexa
• Fortress Diagnostics
• MP Diagnostics
• Healgen
• Bio-Medical Laboratory Supplies
• Creative Diagnostics
• Athenese-Dx
• Biozek Medical
• Diagnostic Automation / Cortez Diagnostics

Hepatitis E Virus Rapid Test Kit Market by Segment

The study includes a forecast for the global hepatitis E virus rapid test kit market by type, application, and region.

Hepatitis E Virus Rapid Test Kit Market by Type [Value from 2019 to 2031]:

• Enzyme-Linked Immunoassay
• Probe Method
• Colloidal Gold Method
• Others

Hepatitis E Virus Rapid Test Kit Market by Application [Value from 2019 to 2031]:

• Diagnostic Center
• Hospital
• Family Expenses

Country Wise Outlook for the Hepatitis E Virus Rapid Test Kit Market

The hepatitis E virus rapid test kit market is witnessing an immense boost due to an increased international consciousness of the virus and the requirement for immediate, precise diagnosis. HEV is a significant etiological agent for acute viral hepatitis in developing countries. Current advancements are aimed at enhancing the speed, sensitivity, and availability of the test, progressing from conventional laboratory-based tests to point-of-care testing. This development is crucial for early detection, outbreak control, and blood safety, especially in endemic regions and for high-risk groups.

• United States: In the United States, the HEV rapid test kit market represents a small but expanding niche market, led primarily by demand to test for non-endemic travel-, zoonotic-, or imported infections. Emerging trends are geared towards high-quality, automated immunoassay platforms that are capable of being inserted into large-scale laboratory testing processes. There is more focus on creating tests that differentiate between acute and remote infections by detecting both IgG and IgM antibodies. There is also a growing presence of specialized kits for immunocompromised patients and blood screening.
• China: Chinas market is a significant force behind global growth because HEV prevalence is high and there is a huge population. Developments that have occurred recently are dominated by the substantial growth of local production of rapid diagnostic kits. They tend to be cheaper, which is vital for mass use. The government has placed emphasis on public health programs in order to stem infectious diseases, and this has resulted in a strong demand for low-cost and effective HEV rapid tests, especially for clinical diagnosis and epidemiological surveillance.
• Germany: Germany possesses a quality-oriented and mature market, together with a high focus on clinical research as well as compliance with European Union standards. Recent progress focuses on the development of more sensitive and specific serological as well as molecular assays. German manufacturers are pioneers in designing kits capable of identifying various HEV genotypes. The market is driven by a need to offer reliable diagnostic products for clinicians to treat severe cases and screen risk groups, including transplant recipients and travelers to endemic regions.
• India: The Indian market is a high-growth market, fueled by the high incidence of HEV outbreaks due to contaminated water sources. The latest trends are dominated by the demand for low-cost, user-friendly, and highly sensitive rapid test kits. The market is facing competition from a number of local firms introducing competitively priced products at the expense of imports. There is emphasis on increasing the geographical reach of diagnostic services to rural and rural remote areas to support a faster response in HEV outbreaks and enhance overall public health surveillance.
• Japan: Japan boasts a technologically developed market where there is much emphasis on high-quality and innovative diagnostic equipment. Recent efforts are focused on developing HEV rapid test kits with high sensitivity as well as specificity. Japanese scientists as well as companies are leading the way in the development of assays that can identify the virus using non-conventional specimens, e.g., stool and urine, for further epidemiological research. The market is also driven by interest in screening for HEV in blood donors and organ transplant candidates in order to avoid iatrogenic transmission.

Features of the Global Hepatitis E Virus Rapid Test Kit Market

• Market Size Estimates: Hepatitis E virus rapid test kit market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Hepatitis E virus rapid test kit market size by type, application, and region in terms of value ($B).
• Regional Analysis: Hepatitis E virus rapid test kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis E virus rapid test kit market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis E virus rapid test kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hepatitis E virus rapid test kit market by type (enzyme-linked immunoassay, probe method, colloidal gold method, and others), application (diagnostic center, hospital, and family expenses), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Hepatitis E Virus Rapid Test Kit Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Enzyme-Linked Immunoassay: Trends and Forecast (2019-2031)
• 4.4 Probe Method: Trends and Forecast (2019-2031)
• 4.5 Colloidal Gold Method: Trends and Forecast (2019-2031)
• 4.6 Others: Trends and Forecast (2019-2031)

5. Global Hepatitis E Virus Rapid Test Kit Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Diagnostic Center: Trends and Forecast (2019-2031)
• 5.4 Hospital: Trends and Forecast (2019-2031)
• 5.5 Family Expenses: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Hepatitis E Virus Rapid Test Kit Market by Region

7. North American Hepatitis E Virus Rapid Test Kit Market

• 7.1 Overview
• 7.2 North American Hepatitis E Virus Rapid Test Kit Market by Type
• 7.3 North American Hepatitis E Virus Rapid Test Kit Market by Application
• 7.4 United States Hepatitis E Virus Rapid Test Kit Market
• 7.5 Mexican Hepatitis E Virus Rapid Test Kit Market
• 7.6 Canadian Hepatitis E Virus Rapid Test Kit Market

8. European Hepatitis E Virus Rapid Test Kit Market

• 8.1 Overview
• 8.2 European Hepatitis E Virus Rapid Test Kit Market by Type
• 8.3 European Hepatitis E Virus Rapid Test Kit Market by Application
• 8.4 German Hepatitis E Virus Rapid Test Kit Market
• 8.5 French Hepatitis E Virus Rapid Test Kit Market
• 8.6 Spanish Hepatitis E Virus Rapid Test Kit Market
• 8.7 Italian Hepatitis E Virus Rapid Test Kit Market
• 8.8 United Kingdom Hepatitis E Virus Rapid Test Kit Market

9. APAC Hepatitis E Virus Rapid Test Kit Market

• 9.1 Overview
• 9.2 APAC Hepatitis E Virus Rapid Test Kit Market by Type
• 9.3 APAC Hepatitis E Virus Rapid Test Kit Market by Application
• 9.4 Japanese Hepatitis E Virus Rapid Test Kit Market
• 9.5 Indian Hepatitis E Virus Rapid Test Kit Market
• 9.6 Chinese Hepatitis E Virus Rapid Test Kit Market
• 9.7 South Korean Hepatitis E Virus Rapid Test Kit Market
• 9.8 Indonesian Hepatitis E Virus Rapid Test Kit Market

10. ROW Hepatitis E Virus Rapid Test Kit Market

• 10.1 Overview
• 10.2 ROW Hepatitis E Virus Rapid Test Kit Market by Type
• 10.3 ROW Hepatitis E Virus Rapid Test Kit Market by Application
• 10.4 Middle Eastern Hepatitis E Virus Rapid Test Kit Market
• 10.5 South American Hepatitis E Virus Rapid Test Kit Market
• 10.6 African Hepatitis E Virus Rapid Test Kit Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Hepatitis E Virus Rapid Test Kit Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 CTK Biotech
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Abbexa
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Fortress Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 MP Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Healgen
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Bio-Medical Laboratory Supplies
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Creative Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Athenese-Dx
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Biozek Medical
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Diagnostic Automation / Cortez Diagnostics
  • Company Overview
  • Hepatitis E Virus Rapid Test Kit Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 2.1: Usage of Hepatitis E Virus Rapid Test Kit Market
• Figure 2.2: Classification of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 2.3: Supply Chain of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 3.1: Driver and Challenges of the Hepatitis E Virus Rapid Test Kit Market
• Figure 3.2: PESTLE Analysis
• Figure 3.3: Patent Analysis
• Figure 3.4: Regulatory Environment
• Figure 4.1: Global Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Type
• Figure 4.3: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Type
• Figure 4.4: Trends and Forecast for Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.5: Trends and Forecast for Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.6: Trends and Forecast for Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 4.7: Trends and Forecast for Others in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.1: Global Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Application
• Figure 5.3: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Application
• Figure 5.4: Trends and Forecast for Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.5: Trends and Forecast for Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 5.6: Trends and Forecast for Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Figure 6.1: Trends of the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market ($B) by Region (2025-2031)
• Figure 7.1: North American Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 7.2: Trends of the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 7.3: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 7.4: North American Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 7.5: Trends of the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 7.6: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 7.7: Trends and Forecast for the United States Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 7.8: Trends and Forecast for the Mexican Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Canadian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.1: European Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 8.2: Trends of the European Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 8.3: Forecast for the European Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 8.4: European Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 8.5: Trends of the European Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 8.6: Forecast for the European Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 8.7: Trends and Forecast for the German Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.8: Trends and Forecast for the French Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the Spanish Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Italian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the United Kingdom Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.1: APAC Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 9.2: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 9.3: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 9.4: APAC Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 9.5: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 9.6: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 9.7: Trends and Forecast for the Japanese Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.8: Trends and Forecast for the Indian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Chinese Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the South Korean Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the Indonesian Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.1: ROW Hepatitis E Virus Rapid Test Kit Market by Type in 2019, 2024, and 2031
• Figure 10.2: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2019-2024)
• Figure 10.3: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Type (2025-2031)
• Figure 10.4: ROW Hepatitis E Virus Rapid Test Kit Market by Application in 2019, 2024, and 2031
• Figure 10.5: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2019-2024)
• Figure 10.6: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market ($B) by Application (2025-2031)
• Figure 10.7: Trends and Forecast for the Middle Eastern Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.8: Trends and Forecast for the South American Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the African Hepatitis E Virus Rapid Test Kit Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Hepatitis E Virus Rapid Test Kit Market
• Figure 11.2: Market Share (%) of Top Players in the Global Hepatitis E Virus Rapid Test Kit Market (2024)
• Figure 12.1: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Type
• Figure 12.2: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Application
• Figure 12.3: Growth Opportunities for the Global Hepatitis E Virus Rapid Test Kit Market by Region
• Figure 12.4: Emerging Trends in the Global Hepatitis E Virus Rapid Test Kit Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Hepatitis E Virus Rapid Test Kit Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Hepatitis E Virus Rapid Test Kit Market by Region
• Table 1.3: Global Hepatitis E Virus Rapid Test Kit Market Parameters and Attributes
• Table 3.1: Trends of the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 3.2: Forecast for the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Hepatitis E Virus Rapid Test Kit Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.4: Trends of Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.5: Forecast for Enzyme-Linked Immunoassay in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.6: Trends of Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.7: Forecast for Probe Method in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.8: Trends of Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.9: Forecast for Colloidal Gold Method in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 4.10: Trends of Others in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 4.11: Forecast for Others in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Hepatitis E Virus Rapid Test Kit Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.4: Trends of Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.5: Forecast for Diagnostic Center in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.6: Trends of Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.7: Forecast for Hospital in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 5.8: Trends of Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 5.9: Forecast for Family Expenses in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.1: Trends of the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.2: Forecast for the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.1: Trends of the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.2: Forecast for the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.1: Trends of the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.2: Forecast for the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.1: Trends of the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.2: Forecast for the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Hepatitis E Virus Rapid Test Kit Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Hepatitis E Virus Rapid Test Kit Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Hepatitis E Virus Rapid Test Kit Market (2019-2031)
• Table 11.1: Product Mapping of Hepatitis E Virus Rapid Test Kit Suppliers Based on Segments
• Table 11.2: Operational Integration of Hepatitis E Virus Rapid Test Kit Manufacturers
• Table 11.3: Rankings of Suppliers Based on Hepatitis E Virus Rapid Test Kit Revenue
• Table 12.1: New Product Launches by Major Hepatitis E Virus Rapid Test Kit Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Hepatitis E Virus Rapid Test Kit Market